New York
Sandoz Exits MDL After E. D. New York Finds Product Liability Claims Preempted
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | January 30, 2012The U.S. District Court for the Eastern District of New York granted summary judgment in favor of firm client Sandoz Inc., along with APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc., Teva Parenteral Medicines, Inc., and Hospira,…
2nd Circuit Upholds Contractual Choice-of-Law Provision, Affirms Summary Judgment for GE
Case | Complex Litigation | August 19, 2011The U.S. Court of Appeals for the Second Circuit affirmed summary judgment in favor of Firm client General Electric International, Inc. (“GEII”), bringing to a close a wrongful death and survival action brought against the company…
Second Circuit Affirms Defense Verdict in Favor of Novartis
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | August 29, 2012The Second Circuit affirmed a defense verdict in Hogan v. Novartis Pharm. Corp., 1:06-260-BMC (E.D.N.Y.). On appeal, plaintiff/appellant argued that the district court erred in denying her last-minute request to present testimony from a treating oral…
Eastern District of New York Excludes Entire Testimony from Plaintiff”s Purported Regulatory and Warnings Expert
Case | Pharmaceutical & Medical Device | May 3, 2011Hogan v. Novartis Pharm. Corp., 1:06-cv-00260-BMC-RER (E.D.N.Y. May 3, 2011)